Nov 28 (Reuters) - Neovasc Inc:
* NEOVASC ANNOUNCES PROGRESS ON COSIRA-II CLINICAL TRIAL
* UNDERTAKEN SEVERAL INITIATIVES TO FURTHER ACCELERATE ENROLLMENT IN TRIAL
* AIMS TO COMPLETE RANDOMIZATION IN FIRST HALF OF 2024
* TRIAL HAS RECEIVED INVESTIGATIONAL TESTING AUTHORIZATION APPROVAL INCLUDING THREE INITIAL SITES APPROVED BY HEALTH CANADA Source text for Eikon: Further company coverage: